Genetic adjuvant therapy for pancreatic cancer and other solid tumours
- PMID: 18268052
- DOI: 10.1136/gut.2007.135376
Genetic adjuvant therapy for pancreatic cancer and other solid tumours
Comment on
-
Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma.Gut. 2008 Mar;57(3):344-51. doi: 10.1136/gut.2007.130252. Epub 2007 Aug 3. Gut. 2008. PMID: 17675324
Similar articles
-
Gene therapy and pancreatic cancer.Surg Oncol Clin N Am. 1998 Jan;7(1):217-49. Surg Oncol Clin N Am. 1998. PMID: 9443997 Review.
-
A "friendly merger" in the war on cancer.Mol Ther. 2000 Feb;1(2):115-6. doi: 10.1006/mthe.2000.0035. Mol Ther. 2000. PMID: 10933920 No abstract available.
-
Current status of gene therapy for pancreatic cancer.Curr Surg. 2004 Jan-Feb;61(1):84-92. doi: 10.1016/j.cursur.2003.07.023. Curr Surg. 2004. PMID: 14972178 Review.
-
Targeting gene therapy--a reality?Mol Ther. 2000 Feb;1(2):117-8. doi: 10.1006/mthe.1999.0024. Mol Ther. 2000. PMID: 10933921 No abstract available.
-
[Present status of and prospects for basic research on pancreatic cancer].Zhonghua Yi Xue Za Zhi. 2008 Jul 22;88(28):1945-7. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19062731 Chinese. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical